EXCLUSIVE: Vienna’s New Job – Helping Cancer Patients

Jake Pavelka’s ex, Vienna Girardi, is doing what any good gal does after a bad break-up – she’s throwing herself into work!

Radaronline.com spoke exclusively to Vienna’s new boss, Leonard Buchanan, who told us she started her new job off right Monday at her marketing gig for a company called Biolustre, and that he’s  “really impressed with her” and that “she really wants to dig into the job.”  He added, “She told me she is looking for a job where she can use her marketing skills.”

EXCLUSIVE PHOTOS: See Vienna In Bikini Thong Contest

According to Buchanan, Vienna’s new job is to act as the main point person when it comes to setting up free treatments to cancer patients.

Biolustre’s product line helps with hair restoration, and the company has a charitable foundation called the Heart of Biolustre Foundation, which provides free treatments to cancer patients around the country.

PHOTOS: Jake’s Slim, Trim Dancing With The Stars Body

Vienna’s work backgound is a perfect fit for the company, according to Buchanan. Vienna has done charitable works since her early 20s and that, paired with her marketing skills, makes her a perfect fit.

EXCLUSIVE: Vienna: I’m Still Afraid Of Jake

“Vienna’s undergone her own battle with cancer with her mother. It’s important that she understands the product and how it works. This product is unlike anything on the market now,” Buchanan told us.

“With technological advances, we are able to do things with hair that was unheard of ten years ago.”

PHOTOS: Jake And Vienna In Hawaii

Vienna officially started her first day at work Monday by training in Los Angeles at Biolustre’s training facility, but Vienna actually started work last week, when she was briefed in the various products the company offers, and even given a Biolustre treatment.

EXCLUSIVE INTERVIEW: “Jake’s A Weirdo” Says Bachelor Contestant Who Refused To Have Sex With Him

With Vienna’s help, the company is looking to expand their product line, so that it’s more widely availible to patients undergoing chemotherapy.

blog comments powered by Disqus